Skip to main content
logo
SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea flag South Korea · Delayed Price · Currency is KRW
98,000
-600 (-0.61%)
At close: Sep 1, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
New Pharmaceutical
1,142.25B
Log In
Log In
Log In
Log In
Upgrade
New Pharmaceutical Growth
221.86%
Log In
Log In
Log In
Log In
Upgrade
Important Adjustments
-594.66B
Log In
Log In
Log In
Log In
Upgrade
Service
-
Log In
Log In
Log In
Log In
Upgrade
Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Important Adjustments
-594.66B
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Important Adjustments
-594.66B
Log In
Log In
Log In
Log In
Upgrade
Important Adjustments Growth
27.97%
Log In
Log In
Log In
Log In
Upgrade
United States
667.82B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
31.23%
Log In
Log In
Log In
Log In
Upgrade
South Korea
474.43B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
52.69%
Log In
Log In
Log In
Log In
Upgrade
Important Adjustments
-594.66B
Log In
Log In
Log In
Log In
Upgrade
Important Adjustments Growth
27.97%
Log In
Log In
Log In
Log In
Upgrade
Cayman Islands
-
Log In
Log In
Log In
Log In
Upgrade
Netherlands
-
Log In
Log In
Log In
Log In
Upgrade
Canada
-
Log In
Log In
Log In
Log In
Upgrade
Japan
-
Log In
Log In
Log In
Log In
Upgrade
Ireland
-
Log In
Log In
Log In
Log In
Upgrade